SCHEMBL2183885

SCHEMBL2183885

O=C=Nc1ccccc1C=S

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.47
TRPA1 O75762 1/20 0.33
TDP1 Q9NUW8 3/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
ABCB11 O95342 1/20 0.31
NR3C1 P04150 1/20 0.31
CYP1A2 P05177 1/20 0.31
ADRA2A P08913 1/20 0.31
ADORA3 P0DMS8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3099538 0.83 CYP3A4 (0.50) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL31168163 0.83 CYP3A4 (0.50) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL5551100 0.83 CYP3A4 (0.50) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL10890112 0.83 CYP3A4 (0.50) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL7190691 0.81 TDP1 (0.50) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL465790 0.79 CYP3A4 (0.47) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL3591773 0.79 CYP3A4 (0.52) CYP3A4TRPA1TDP1MEN1LMNA
Water SCHEMBL27519980 0.79 TDP1 (0.48) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL15528637 0.79 CYP3A4 (0.47) CYP3A4TRPA1TDP1MEN1LMNA
SCHEMBL29395383 0.77 CYP3A4 (0.64) CYP3A4TRPA1TDP1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222314-B2 Phenyl isocyanate-based urethane acrylates, processes for producing and methods of using the same BAYER MATERIALSCIENCE AG (DE) 2012-07-17 US claimed
EP-2154129-A1 Phenylisocyanate based urethanacrylate with high refraction index Bayer MaterialScience AG (DE) 2010-02-17 EP claimed
EP-2154128-A1 Phenylisocyanate based urethanacrylates with high refraction index Bayer MaterialScience AG (DE) 2010-02-17 EP claimed
US-20100036013-A1 PHENYL ISOCYANATE-BASED URETHANE ACRYLATES, PROCESSES FOR PRODUCING AND METHODS OF USING THE SAME BAYER MATERIALSCIENCE AG (DE) 2010-02-11 US claimed
CN-101704773-B Phenyl isocyanate-based urethane acrylates, processes for making and methods of using the same BAYER MATERIALSCIENCE AG 2014-03-05 CN disclosed
US-8222314-B2 Phenyl isocyanate-based urethane acrylates, processes for producing and methods of using the same BAYER MATERIALSCIENCE AG (DE) 2012-07-17 US disclosed
EP-2342249-A1 PREPOLYMER-BASED POLYURETHANE FORMULATIONS FOR PRODUCING HOLOGRAPHIC MEDIA Bayer MaterialScience AG (DE) 2011-07-13 EP disclosed
CN-101704773-A Phenyl isocyanate-based urethane acrylates, processes for making and methods of using the same BAYER MATERIALSCIENCE AG 2010-05-12 CN disclosed
WO-2010037496-A1 PREPOLYMER-BASED POLYURETHANE FORMULATIONS FOR PRODUCING HOLOGRAPHIC MEDIA BAYER MATERIALSCIENCE AG (DE) 2010-04-08 WO disclosed
EP-2154129-A1 Phenylisocyanate based urethanacrylate with high refraction index Bayer MaterialScience AG (DE) 2010-02-17 EP disclosed
EP-2154128-A1 Phenylisocyanate based urethanacrylates with high refraction index Bayer MaterialScience AG (DE) 2010-02-17 EP disclosed
US-20100036013-A1 PHENYL ISOCYANATE-BASED URETHANE ACRYLATES, PROCESSES FOR PRODUCING AND METHODS OF USING THE SAME BAYER MATERIALSCIENCE AG (DE) 2010-02-11 US disclosed
US-6653295-B2 Protease inhibitor; viricide BRISTOL-MYERS SQUIBB COMPANY 2003-11-25 US disclosed
US-20030064962-A1 Inhibitors of hepatitis C virus NS3 protease BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030064962-A1 Inhibitors of hepatitis C virus NS3 protease PRSS1, SERPINB1, SPINT2 CYP3A4 135/4885TRPA1 4380/4885TDP1 1691/4885
US-20100036013-A1 PHENYL ISOCYANATE-BASED URETHANE ACRYLATES, PROCESSES FOR PRODUCING AND METHODS OF USING THE SAME GRHPR, CBR1, C1S CYP3A4 783/4885TRPA1 307/4885TDP1 1202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.